New appointments at BrainCells
This article was originally published in Scrip
Executive Summary
The US drug discovery and development company BrainCells has named Dr Philip Jochelson chief medical officer and Jason Levin chief business officer. Dr Jochelson, who succeeds Steve Targum, was formerly senior vice-president of development and chief medical officer at Somaxon, while Mr Levin previously served as vice-president of corporate development at Jazz Pharmaceuticals.